Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 300Carcinoma, Non-Small-Cell Lung 224Neoplasms 193Prostatic Neoplasms 164Multiple Myeloma 140Neoplasm Metastasis 118Melanoma 113Colorectal Neoplasms 107Leukemia, Myeloid, Acute 105Lung Neoplasms 98Lymphoma 97Ovarian Neoplasms 84Squamous Cell Carcinoma of Head and Neck 77Lymphoma, Non-Hodgkin 74Leukemia, Lymphocytic, Chronic, B-Cell 72Triple Negative Breast Neoplasms 64Pancreatic Neoplasms 64Myelodysplastic Syndromes 64Hematologic Neoplasms 60Precursor Cell Lymphoblastic Leukemia-Lymphoma 59Parkinson Disease 4, Autosomal Dominant Lewy Body 59Head and Neck Neoplasms 59Glioblastoma 58Recurrence 56Leukemia 55Sarcoma 50Brain Neoplasms 49Lymphoma, Large B-Cell, Diffuse 48Carcinoma, Hepatocellular 47Lymphoma, Follicular 46

Interventions

Metformin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Metabolic Syndrome × 1 year × Clear all
NCT02500147 2025-07-02

Metformin for Ectopic Fat Deposition and Metabolic Markers in Polycystic Ovary Syndrome (PCOS)

Columbia University

Phase 4 Terminated
3 enrolled 5 charts

Acne Vulgaris, Amenorrhea, Hirsutism, Polycystic Ovary Syndrome, Metabolic Syndrome, Dyslipidemias, Non-alcoholic Fatty Liver Disease

Data powered by HemOnc (CC BY 4.0) Colophon âš¡